Penicillin Use in Meningococcal Disease Management: Active Bacterial Core Surveillance Sites, 2009-Reference-Cited by-同舟云学术

Penicillin Use in Meningococcal Disease Management: Active Bacterial Core Surveillance Sites, 2009

Published:2016 Issue:3 Volume:3 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Blain Amy E.¹,Mandal Sema¹,Wu Henry¹,MacNeil Jessica R.¹,Harrison Lee H.²,Farley Monica M.³,Lynfield Ruth⁴,Miller Lisa⁵,Nichols Megin⁶,Petit Sue⁷,Reingold Arthur⁸,Schaffner William⁹,Thomas Ann¹⁰,Zansky Shelley M.¹¹,Anderson Raydel¹,Harcourt Brian H.¹,Mayer Leonard W.¹,Clark Thomas A.¹,Cohn Amanda C.¹

Affiliation:

1. Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia

2. Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland

3. Department of Medicine, Emory University School of Medicine and the Atlanta VA Medical Center, Georgia

4. Minnesota Department of Health, St. Paul

5. Colorado Department of Public Health and Environment, Denver

6. New Mexico Department of Health, Sante Fe

7. Connecticut Department of Public Health, Hartford

8. School of Public Health, University of California, Berkley

9. Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee

10. Oregon Department of Human Services, Portland

11. New York State Department of Health, Albany

Abstract

Abstract In 2009, in the Active Bacterial Core surveillance sites, penicillin was not commonly used to treat meningococcal disease. This is likely because of inconsistent availability of antimicrobial susceptibility testing and ease of use of third-generation cephalosporins. Consideration of current practices may inform future meningococcal disease management guidelines.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

http://academic.oup.com/ofid/article-pdf/3/3/ofw152/33621976/ofw152.pdf

Reference9 articles.

1. Acute meningitis;Tunkel,2005

2. Practice guidelines for the management of bacterial meningitis;Tunkel;Clin Infect Dis,2004

3. Meningococcal infections;American Academy of Pediatrics,2015

4. Active Bacterial Core surveillance (ABCs);Centers for Disease Control and Prevention

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antimicrobial Susceptibility Survey of Invasive Neisseria meningitidis, United States 2012–2016;The Journal of Infectious Diseases;2022-03-10

2. β-Lactamase–Producing, Ciprofloxacin-Resistant Neisseria meningitidis Isolated From a 5-Month-Old Boy in the United States;Journal of the Pediatric Infectious Diseases Society;2020-08-03

3. Detection of Ciprofloxacin-Resistant, β-Lactamase–Producing Neisseria meningitidis Serogroup Y Isolates — United States, 2019–2020;MMWR. Morbidity and Mortality Weekly Report;2020-06-19

4. Meningococcal Capsular Group A, C, W, and Y Conjugate Vaccines;Plotkin's Vaccines;2018